Cited by 128Alzheimer's disease research and treatmentsMass Spectrometry Techniques and ApplicationsProtein purification and stability

Amyloid β Protein: Aβ40 Inhibits Aβ42 Oligomerization

Open access
Murray, Megan M., Bernstein, Summer L., Nyugen, Vy, Condron, Margaret M., Teplow, David B., Bowers, Michael T.·2009·Journal of the American Chemical Society

Abstract

Abeta40 and Abeta42 are peptides that adopt similar random-coil structures in solution. Abeta42, however, is significantly more neurotoxic than Abeta40 and forms amyloid fibrils much more rapidly than Abeta40. Here, mass spectrometry and ion mobility spectrometry are used to investigate a mixture of Abeta40 and Abeta42. The mass spectrum for the mixed solution shows the presence of a heterooligomer composed of equal parts of Abeta40 and Abeta42. Ion mobility results indicate that this mixed species comprises an oligomer distribution extending to tetramers. Abeta40 alone produces such a distribution, whereas Abeta42 alone produces oligomers as large as dodecamers. This indicates that Abeta40 inhibits Abeta42 oligomerization.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/ja8092604

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Almost all previous studies investigating the effect of bifunctional compounds on the neurotoxicity of metal-Aβ species have focused on the less neurotoxic and possibly even anti-amyloidogenic Aβ40 peptide.

    “Almost all previous studies investigating the effect of bifunctional compounds on the neurotoxicity of metal-Aβ species have focused on the less neurotoxic and possibly even anti-amyloidogenic Aβ40 peptide.9,97,98”

    From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ<sub>42</sub>Peptide (2012) · cites this paper as [97]

    The paper’s Abstract (page unavailable) says Aβ42 is significantly more neurotoxic than Aβ40 and reports that Aβ40 inhibits Aβ42 oligomerization, supporting the description of Aβ40 as less neurotoxic and possibly anti-amyloidogenic. It does not address whether almost all previous studies of bifunctional compounds and metal-Aβ neurotoxicity focused on Aβ40. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 18

  1. [1]Roychaudhuri R Mingfeng Y Hoshi MM Teplow DB Journal of Biological Chemistry 2008
  2. [2]Dahlgren KN Manelli AM Stine WB Baker LK Krafft GA LaDu MJ Journal of Biological Chemistry 2002 277 35 32046 32053 12058030
  3. [3]Bitan G Kirkitadze MD Lomakin A Vollers SS Benedek GB Teplow DB Proc Natl Acad Sci USA 2003 100 1 330 335 12506200 PMC140968
  4. [4]Lesne S Koh MT Kotilinek L Kayed R Glabe CG Yang A Gallagher M Ashe KH Nature 2006 440 7082 352 357 16541076
  5. [5]Klein WL Stine WB Teplow DB Neurobiology of Aging 2004 25 5 569 580 15172732
  6. [6]Jan A Gokce o Luthi-Carter R Lashuel HA The Journal of Biological Chemistry 2008 283 42 28176 28180 18694930 PMC2661389
  7. [7]Yan YL Wang CY Journal of Molecular Biology 2007 369 4 909 916 17481654
  8. [8]Kim J Onstead L Randle S Price R Smithson L Zwizinski C Dickson D Golde T McGowan E The Journal of Neuroscience 2007 27 3 627 633 17234594 PMC6672801
  9. [9]Bowers MT Kemper PR Vonhelden G Vankoppen PAM Science 1993 260 5113 1446 1451 17739800
  10. [10]Clemmer DE Jarrold MF Journal of Mass Spectrometry 1997 32 6 577 592
  11. [12]Vonhelden G Hsu MT Kemper PR Bowers MT Journal of Chemical Physics 1991 95 5 3835 3837
  12. [13]Bernstein SL Wyttenbach T Baumketner A Shea JE Bitan G Teplow DB Bowers MT Journal of the American Chemical Society 2005 127 7 2075 2084 15713083
  13. [14]Baumketner A Bernstein SL Wyttenbach T Bitan G Teplow DB Bowers MT Shea JE Protein Science 2006 15 420 428 16501222 PMC2249763
  14. [15]Murray M Krone M Bernstein S Wyttenbach T Condron M Teplow DB Shea J Bowers MT Submitted for publication 2008 PMC2597412 18597778
  15. [16]Wu C Murray M Bernstein S Condron M Bitan G Shea JE Bowers MT Journal of Molecular Biology 2009 387 2 492 501 19356595 PMC2712569
  16. [17]Lomakin A Chung DS Benedek GB Kirschner DA Teplow DB Proceedings of the National Academy of Sciences of the United States of America 1996 93 3 1125 1129 8577726 PMC40042
  17. [18]Wyttenbach T Kemper PR Bowers MT International Journal of Mass Spectrometry 2001 212 1–3 13 23
  18. [20]Cheng IH Scearce-Levie K Legleiter J Palop JJ Gerstein H Bien-Ly N Puolivali J Lesne S Ashe KH Muchowski PJ Mucke L Journal of Biological Chemistry 2007 282 33 23818 23828 17548355

Cited by

Sorted by citations

Authors
Murray, M. M., Bernstein, S. L., Nyugen, V., Condron, M. M., Teplow, D. B., & Bowers, M. T.
Affiliations
University of California, Santa Barbara (US)
Corresponding author
Bowers, Michael T.
Venue
Journal of the American Chemical Society
Published
2009-04-22
Volume
131
Issue
18
Pages
6316-6317
ISSN
  • 0002-7863 (ISSN-L)
  • 1520-5126
OpenAlex
W1991634503
Cited by
128
References
3
Citations by year
2026: 6 · 2025: 3 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 9 · 2017: 7 · 2016: 7 · 2015: 13 · 2014: 9 · 2013: 10 · 2012: 14
FWCI
8.64
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Chemical Society (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institutes of Health
  • U.S. Public Health Service (IPOIAG027818)
  • National Institute on Aging (P01AG027818)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Physical Sciences › Chemistry › Spectroscopy › Mass Spectrometry Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
Keywords
amyloid-beta, Aβ40, amyloid-beta 42, oligomerization inhibition, hetero-oligomers, amyloid fibrils, neurotoxicity, oligomer size distribution, tetramer, dodecamer, Alzheimer's disease
MeSH terms
Amyloid, Peptide Fragments, Spectrum Analysis, Structure-Activity Relationship, Amyloid beta-Peptides, Protein Structure, Secondary, Protein Multimerization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review